EndaCof DM - 68047-143-16 - (Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride)

Alphabetical Index


Drug Information of EndaCof DM

Product NDC: 68047-143
Proprietary Name: EndaCof DM
Non Proprietary Name: Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride
Active Ingredient(s): 1; 5; 2.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of EndaCof DM

Product NDC: 68047-143
Labeler Name: Larken Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20120330

Package Information of EndaCof DM

Package NDC: 68047-143-16
Package Description: 473 mL in 1 BOTTLE (68047-143-16)

NDC Information of EndaCof DM

NDC Code 68047-143-16
Proprietary Name EndaCof DM
Package Description 473 mL in 1 BOTTLE (68047-143-16)
Product NDC 68047-143
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20120330
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Larken Laboratories, Inc.
Substance Name BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 1; 5; 2.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of EndaCof DM


General Information